Related Experiment Video
Updated: Jan 27, 2026

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
C188-9, a small-molecule STAT3 inhibitor, exerts an antitumor effect on head and neck squamous cell carcinoma
1Department of Otorhinolaryngology.
Abstract:
Abnormal activation of signal transducer and activator of transcription 3 (STAT3) is complicated in the tumor progression of multiple cancers including human head and neck squamous cell carcinoma (HNSCC) and, therefore, serves as a potent therapeutic target. In this study, we identify that C188-9, a small-molecule STAT3 inhibitor, exhibits an antitumor effect on HNSCC in vitro. C188-9 significantly inhibits cell growth, arrests cell cycle at G0/G1 phase, and induces apoptosis in HNSCC. Besides, the capacities of migration and invasion of HNSCC cells are impaired with the exposure to C188-9. In addition, C188-9 treatment enhanced the chemosensitivity of HNSCC cellsin vitro. Moreover, C188-9 inactivates STAT3 by reducing its phosphorylation at Tyr705. Taken together, these results indicate that C188-9 could be a promising therapeutic strategy for patients suffered from HNSCC by suppressing the STAT3 pathway.
Insights
C188-9, a STAT3 inhibitor, shows antitumor effects against human head and neck squamous cell carcinoma (HNSCC) by inhibiting growth, migration, and invasion. This STAT3 suppression offers a promising therapeutic strategy for HNSCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Signal transducer and activator of transcription 3 (STAT3) pathway dysregulation is implicated in human head and neck squamous cell carcinoma (HNSCC) progression.
- STAT3 is a validated therapeutic target for various cancers, including HNSCC.
Purpose of the Study:
- To investigate the antitumor potential of C188-9, a novel small-molecule STAT3 inhibitor, against HNSCC.
- To elucidate the molecular mechanisms underlying C188-9's effects on HNSCC cells.
Main Methods:
- In vitro assessment of C188-9's impact on HNSCC cell proliferation, cell cycle, apoptosis, migration, and invasion.
- Evaluation of C188-9's effect on HNSCC chemosensitivity.
- Analysis of STAT3 phosphorylation at Tyr705 following C188-9 treatment.
Main Results:
- C188-9 significantly inhibited HNSCC cell growth, induced G0/G1 cell cycle arrest, and promoted apoptosis.
- C188-9 exposure reduced HNSCC cell migration and invasion capacities.
- C188-9 enhanced the chemosensitivity of HNSCC cells and inactivated STAT3 by decreasing Tyr705 phosphorylation.
Conclusions:
- C188-9 demonstrates potent antitumor activity against HNSCC in vitro.
- Suppression of the STAT3 pathway by C188-9 represents a promising therapeutic avenue for HNSCC management.
More Related Videos
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Muscles of the Anterior Neck
Muscles that Move the Head
The bilateral sternocleidomastoid, or SCM, and the suprahyoid and infrahyoid muscles are significant head flexors. The SCM muscles originate at the sternum and clavicle and attach to the mastoid process of the temporal bone. The SCM contracts bilaterally to bend the head forward, whereas...
Molecules and Compounds

